Biotechs will have to scramble for a piece of $1B grant pie

A host of small and mid-sized biotech companies are massing at the starting line for the federal government's $1 billion tax credit/grant program. And a Treasury spokesperson told the Wall Street Journal that details on applying for the money are expected at any moment now. Speed will be of the essence for any developer looking to get a piece of this action. Slipped into the healthcare reform package at the urging of BIO, the government will provide 50 percent of the 2009 and 2010 project...

E&Y: 2009 forever changed the biopharma industry

CHICAGO - The sting of the 2008/2009 economic crisis is starting to fade. But last year's crisis was so different, so widespread and so global that it has forever changed the way biotech and pharmaceutical companies look at drug development, bringing about a "new normal" for the industry. That's according to Ernst & Young, which yesterday put out its annual look at the drug development industry. Last year wasn't all bad news for the industry. Biotech demonstrated unprecedented industry...